Kathy Wilkinson on the Nurse's Role in Clinical Trials

Video
Conferences|ONS Annual Congress

Kathy Wilkinson, RN, BSN, OCN, Manager, Cancer Research, Billings Clinic Cancer Center, discusses the role that nurse's play in clinical trials.

Kathy Wilkinson, RN, BSN, OCN, Manager, Cancer Research, Billings Clinic Cancer Center, discusses the role that nurses play in clinical trials.

Wilkinson says a nurse’s relationship with a patient puts them in a prime position to talk about clinical trials. Nurses can educate patients about clinical trials and explain concepts to patients in terms that they can understand. Wilkinson says patients trust nurses to give them accurate information about what the trial is going to entail, including potential side effects.

<<<

View more from the 40th Annual ONS Congress

Recent Videos
a man wearing a suit and tie in front of a green screen with the ONN logo
Related Content
illustration of the gastrointestinal tract with people in lab coats around the drawing

ctDNA Status May Be Prognostic for DFS With Celecoxib for Stage III Resected Colon Cancer

Ashling Wahner
January 26th 2025
Article

While ctDNA positivity was linked to worse overall disease-free survival (DFS) in stage III resected colon cancer, it was associated with significantly improved DFS with celecoxib compared to placebo.

The Vitals

Lauren Mahon Offers Nurse Perspectives on PARP Inhibitors As Ovarian Cancer Maintenance Therapy

Lindsay Fischer
June 15th 2023
Podcast

Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.

older woman sitting at a table with a glass of water

Baseline Geriatric Assessment and QOL Impact Chemotherapy Survival in Pancreatic Cancer

Roman Fabbricatore
January 25th 2025
Article

The EA2186 trial was the first study specifically designed to test chemotherapy in older adults with advanced pancreatic cancer who were considered vulnerable.

The Vitals

Seth Eisenberg Discusses New Methods of Reducing Hazardous Drug–Contaminated Toilet Aerosols in Hospital Setting

Lindsay Fischer
June 1st 2023
Podcast

Seth Eisenberg, ASN, RN, OCN, BMTCN, emphasizes the importance of reducing nurse exposure to hazardous drugs—and ongoing research efforts to improve nursing safety.

a pink background with a figure of the colorectal area of the body

Bevacizumab’s Benefit in Colorectal Cancer May Be Limited to 2 Years Post-Administration

Darlene Dobkowski, MA
January 25th 2025
Article

The 2-year benefit of bevacizumab in colorectal cancer may explain why survival benefits are seen in studies with two-year, but not longer, follow-ups.

Simple yellow line illustration of a liver on a dark blue background

Nivolumab Plus Ipilimumab Offers Improved Survival and Response Rates in First-Line uHCC

Jordyn Sava
January 25th 2025
Article

First-line nivolumab plus ipilimumab was shown to be effective and well-tolerated in patients with unresectable hepatocellular carcinoma in the CheckMate 9DW study.